# Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

> **NCT02083718** · PHASE2 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Stem Cell Transplantation, Hematopoietic
- Poor Graft Function
- Hematological Diseases

## Interventions

- **BIOLOGICAL:** PBSC
- **BIOLOGICAL:** MSCs

## Key facts

- **NCT ID:** NCT02083718
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2016-01
- **Final completion:** 2017-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083718, "Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02083718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*